Revised forecast
Fiscal year ending March 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
In the directly operated massage business, the company will recruit and train practitioners, improve operational efficiency, and acquire new users. In the massage franchise business, it will continue promotional activities and support for franchise locations. In the medical care business, it will focus on improving the profitability of its 6 existing locations and strengthening promotional efforts for home-visit nursing offices.
Loss on disposal of fixed assets: ¥421 thousand; loss on cancellation of leases: ¥3,247 thousand; total extraordinary losses: ¥3,669 thousand
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥6,586 million（Compared with the previous fiscal year: △13.8%） |
| Operating profit | Not disclosed → ¥520 million（Compared with the previous fiscal year: 77.5%） |
| Ordinary income | Not disclosed → ¥480 million（Compared with the previous fiscal year: 42.4%） |
| Profit attributable to owners of the parent | Not disclosed → ¥330 million（Compared with the previous fiscal year: △35.1%） |
| Net income per share | Not disclosed → 126.5 yen and sen（Compared with the previous fiscal year: △35.1%） |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Previous-period results | Net sales: ¥7,637 million; operating income: ¥293 million; ordinary income: ¥337 million; net income attributable to owners of the parent: ¥508 million; net income per share: ¥196.21 |
| Reason for the revision | In the directly operated massage business, the company will recruit and train practitioners, improve operational efficiency, and acquire new users. In the massage franchise business, it will continue promotional activities and support for franchise locations. In the medical care business, it will focus on improving the profitability of its 6 existing locations and strengthening promotional efforts for home-visit nursing offices. |
| Details and amount of extraordinary loss | Loss on disposal of fixed assets: ¥421 thousand; loss on cancellation of leases: ¥3,247 thousand; total extraordinary losses: ¥3,669 thousand |
| Dividend forecast revision | The filing presents a year-end dividend forecast of ¥10.57 per share and an annual dividend forecast of ¥10.57 per share for the fiscal year ending March 2027. No revision is explicitly stated. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the fiscal year ended March 2026, performance was affected by higher treatment fees following the revision of medical treatment reimbursements, increases in the number of users and treatments through sales activities, and business transfers. For the fiscal year ending March 2027, the company plans to recruit and train practitioners, improve operational efficiency and advance DX, expand franchise locations, and improve the profitability of its 6 existing locations.